Poster Abstract Session:
072. Microbiome
Thursday, October 5, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD


Presentations:
629
The Gut Microbiome in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients
Amruta Padhye, MD; Kristine Wylie, PhD; Shalini Shenoy, MD; Kusal Mihindukulasuriya, MS; Gregory Storch, MD
Posters
  • IDSA poster 10_4_2017.pdf (1.9 MB)
  • 630
    SYN-006, a Novel Carbapenemase, Intended to Protect the Gut Microbiome from Antibiotic-Mediated Damage May Also Reduce Propagation of Carbapenem-Resistant Pathogens
    Michael Kaleko, MD, PhD; Christian Furlan-Freguia, PhD; Poorani Subramanian, PhD; Nur A. Hasan, PhD; Rita R. Colwell, PhD; Sheila Connelly, PhD
    631
    The Impact of Antibiotic Use in Breastfeeding Women on the Infant’s Gut Microbiome - A Prospective Cohort Study.
    Rachel Rock, MD; Hila Ben-Amram, MA; Hadar Neuman, PhD; Hodaya Hanya, BSc; Omry Koren, PhD; Ilan Youngster, MD, MMSc
    632
    HIV-Associated Changes in the Gut Microbiome in Untreated, Treated, and Immunologically Controlled Disease
    Jesus Luevano Jr., BA; David Gootenberg, BA; Jeffrey Paer, BA; Zoe Rogers, BA; Douglas Kwon, MD, PhD
    Posters
  • ID Week Poster_JLuevano.pdf (3.2 MB)
  • 633
    Gut Antibiotic Inactivation by Beta-Lactamases Is Intended to Prevent Microbiome Damage and Attenuate Antibiotic Resistance in Large Animal Models
    Sheila Connelly, PhD; Christian Furlan-Freguia, PhD; Poorani Subramanian, PhD; Nur A. Hasan, PhD; Rita R. Colwell, PhD; Michael Kaleko, MD, PhD
    634
    Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana
    Matthew Kelly, MD, MPH; Michael Surette, MD; Marek Smieja, MD, PhD; Laura Rossi, BSc; Kathy Luinstra, BSc; Andrew Steenhoff, MBBCh, DCH; David Goldfarb, MD, FRCPC; Tonya Arscott-Mills, MD, MPH; Sefelani Boiditswe, BNSc; Ikanyeng Rulaganyang, BNSc; Charles Muthoga, BSc; Kwana Lechiile, BSc; Tiny Mazhani, MD; John Rawls, PhD; Coleen Cunningham, MD; Samir Shah, MD; Kristen Feemster, MD, MPH, MSHP; Patrick Seed, MD, PhD
    635
    Impact of Proton Pump Inhibitor Use on Gut Microbiota Composition and Other Markers of Health in Older Adults
    Kelly R. Reveles, PharmD, PhD; R. Joel Moore, PharmD; Reese A. Cosimi, PharmD; Caitlin N. Ryan, PhD; Luisa S. Chan, MS; Wanda L. Haynes, BSN
    636
    The Lung Tissue Microbiota of Mild and Moderate Chronic Obstructive Pulmonary Disease
    Alexa A. Pragman, MD, PhD; Tianmeng Lyu, BS; Joshua A. Baller, Ph.D.; Trevor Gould, MS; Rosemary F. Kelly, M.D.; Cavan S. Reilly, PhD; Richard E. Isaacson, PhD; Chris H. Wendt, MD
    Posters
  • IDWeek 2017 Poster.pdf (1.1 MB)
  • 640
    Changes in the Oropharyngeal Microbiome Preceding Ventilator-Associated Pneumonia
    Rami Sommerstein, MD; Tobias Merz, MD; Sabine Berger, RN; Moana Mika, PhD; Jonas Marschall, MD; Markus Hilty, PhD
    Posters
  • p640.pdf (471.6 kB)
  • 641
    High Dietary Fiber is Associated with Reduced Prevalence of Gut Colonization by Multi-Drug Resistant Organisms
    Shoshannah Eggers, BS; Kristen Malecki, PhD, MPH; Paul Peppard, PhD; Julie Mares, PhD; Daniel Shirley, MD, MS; Sanjay Shukla, PhD; Keith Poulsen, DVM, PhD; Ronald Gangnon, PhD; Garret Suen, PhD; Ajay Sethi, PhD, MHS; Nasia Safdar, MD, PhD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.